CELC
Price
$86.00
Change
+$0.85 (+1.00%)
Updated
Nov 13 closing price
Capitalization
3.65B
125 days until earnings call
Intraday BUY SELL Signals
GLSI
Price
$8.22
Change
+$0.02 (+0.24%)
Updated
Nov 14, 11:06 AM (EDT)
Capitalization
113.33M
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs GLSI

Header iconCELC vs GLSI Comparison
Open Charts CELC vs GLSIBanner chart's image
Celcuity
Price$86.00
Change+$0.85 (+1.00%)
Volume$1.2M
Capitalization3.65B
Greenwich LifeSciences
Price$8.22
Change+$0.02 (+0.24%)
Volume$240
Capitalization113.33M
CELC vs GLSI Comparison Chart in %
CELC
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CELC vs. GLSI commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Buy and GLSI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CELC: $86.00 vs. GLSI: $8.20)
Brand notoriety: CELC and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 104% vs. GLSI: 120%
Market capitalization -- CELC: $3.65B vs. GLSI: $113.33M
CELC [@Biotechnology] is valued at $3.65B. GLSI’s [@Biotechnology] market capitalization is $113.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 1 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 1 green, 4 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 5 bearish.
  • GLSI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CELC is a better buy in the short-term than GLSI.

Price Growth

CELC (@Biotechnology) experienced а +15.90% price change this week, while GLSI (@Biotechnology) price change was -0.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

CELC is expected to report earnings on Mar 19, 2026.

GLSI is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($3.65B) has a higher market cap than GLSI($113M). CELC YTD gains are higher at: 556.990 vs. GLSI (-26.981). GLSI has higher annual earnings (EBITDA): -18.14M vs. CELC (-135.56M). CELC has more cash in the bank: 168M vs. GLSI (3.13M). CELC (0) and GLSI (0) have equivalent revenues.
CELCGLSICELC / GLSI
Capitalization3.65B113M3,230%
EBITDA-135.56M-18.14M747%
Gain YTD556.990-26.981-2,064%
P/E RatioN/AN/A-
Revenue00-
Total Cash168M3.13M5,376%
Total Debt99.4MN/A-
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCGLSI
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 22 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TNYRX10.78-0.05
-0.42%
1290 Loomis Sayles Multi-Asset Income R
HWLZX46.27-0.35
-0.75%
Hotchkis & Wiley Large Cap Fdml Value Z
HAONX16.54-0.17
-1.02%
Harbor International Core Investor
PMBPX44.03-0.70
-1.56%
Principal MidCap R5
PSCHX23.94-0.47
-1.93%
PGIM Jennison Small Company R2

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+1.00%
IMA - CELC
79%
Closely correlated
-2.57%
NEVPF - CELC
61%
Loosely correlated
N/A
MRSN - CELC
58%
Loosely correlated
+209.24%
SLXN - CELC
52%
Loosely correlated
-1.37%
ABOS - CELC
44%
Loosely correlated
-7.18%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CRSP. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-1.50%
CRSP - GLSI
40%
Loosely correlated
-2.07%
MNMD - GLSI
39%
Loosely correlated
-4.20%
ABOS - GLSI
39%
Loosely correlated
-7.18%
IMNM - GLSI
37%
Loosely correlated
-5.28%
CELC - GLSI
37%
Loosely correlated
+1.00%
More